Liu Zu

机构：BGI Group (China), Kunming Medical University, Yan'an Hospital Affiliated To Kunming Medical University

发表论文 47 篇 · 总被引 452 次 · h-index 9

代表论文

• Comprehensive genomic profiling of lung cancer using a validated panel to explore therapeutic targets in East Asian patients (2017 · Cancer Science · 被引 92)
• Emerging Understanding of the Advantage of Small Molecules such as Hydroxypyridinones in the Treatment of Iron Overload (2003 · Current Medicinal Chemistry · 被引 74)
• A targeted next-generation sequencing method for identifying clinically relevant mutation profiles in lung adenocarcinoma (2016 · Scientific Reports · 被引 64)
• Diagnostic Performance of Donor-Derived Plasma Cell-Free DNA Fraction for Antibody-Mediated Rejection in Post Renal Transplant Recipients: A Prospective Observational Study (2020 · Frontiers in Immunology · 被引 58)
• Effect of bone marrow mesenchymal stem cells on the polarization of macrophages (2018 · Molecular Medicine Reports · 被引 42)
• Development and clinical validation of a circulating tumor DNA test for the identification of clinically actionable mutations in nonsmall cell lung cancer (2017 · Genes Chromosomes and Cancer · 被引 34)